vs
REPLIGEN CORP（RGEN）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是REPLIGEN CORP的1.6倍（$324.4M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 5.7%，领先1.0%），REPLIGEN CORP同比增速更快（13.6% vs 10.4%），REPLIGEN CORP自由现金流更多（$17.6M vs $-13.3M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.5%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
RGEN vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出3.2%
10.4%
净利率更高
RGEN
高出1.0%
5.7%
自由现金流更多
RGEN
多$30.8M
$-13.3M
两年增速更快
RGEN
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $197.9M | $324.4M |
| 净利润 | $13.3M | $18.6M |
| 毛利率 | 52.5% | 53.3% |
| 营业利润率 | 9.0% | 6.3% |
| 净利率 | 6.7% | 5.7% |
| 营收同比 | 13.6% | 10.4% |
| 净利润同比 | 143.9% | 50.4% |
| 每股收益（稀释后） | $0.24 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGENRVLV
| Q4 25 | $197.9M | $324.4M | ||
| Q3 25 | $188.8M | $295.6M | ||
| Q2 25 | $182.4M | $309.0M | ||
| Q1 25 | $169.2M | $296.7M | ||
| Q4 24 | $174.1M | $293.7M | ||
| Q3 24 | $154.9M | $283.1M | ||
| Q2 24 | $154.1M | $282.5M | ||
| Q1 24 | $151.3M | $270.6M |
净利润RGENRVLV
| Q4 25 | $13.3M | $18.6M | ||
| Q3 25 | $14.9M | $21.2M | ||
| Q2 25 | $14.9M | $10.2M | ||
| Q1 25 | $5.8M | $11.8M | ||
| Q4 24 | $-30.3M | $12.3M | ||
| Q3 24 | $-654.0K | $11.0M | ||
| Q2 24 | $3.3M | $15.4M | ||
| Q1 24 | $2.1M | $10.9M |
毛利率RGENRVLV
| Q4 25 | 52.5% | 53.3% | ||
| Q3 25 | 53.2% | 54.6% | ||
| Q2 25 | 50.0% | 54.1% | ||
| Q1 25 | 53.6% | 52.0% | ||
| Q4 24 | 26.1% | 52.5% | ||
| Q3 24 | 50.0% | 51.2% | ||
| Q2 24 | 49.8% | 54.0% | ||
| Q1 24 | 49.5% | 52.3% |
营业利润率RGENRVLV
| Q4 25 | 9.0% | 6.3% | ||
| Q3 25 | 8.9% | 7.1% | ||
| Q2 25 | 7.6% | 5.8% | ||
| Q1 25 | 3.9% | 5.0% | ||
| Q4 24 | -17.7% | 3.9% | ||
| Q3 24 | -5.1% | 5.0% | ||
| Q2 24 | 1.0% | 5.8% | ||
| Q1 24 | 1.3% | 3.4% |
净利率RGENRVLV
| Q4 25 | 6.7% | 5.7% | ||
| Q3 25 | 7.9% | 7.2% | ||
| Q2 25 | 8.2% | 3.3% | ||
| Q1 25 | 3.4% | 4.0% | ||
| Q4 24 | -17.4% | 4.2% | ||
| Q3 24 | -0.4% | 3.9% | ||
| Q2 24 | 2.2% | 5.4% | ||
| Q1 24 | 1.4% | 4.0% |
每股收益（稀释后）RGENRVLV
| Q4 25 | $0.24 | $0.27 | ||
| Q3 25 | $0.26 | $0.29 | ||
| Q2 25 | $0.26 | $0.14 | ||
| Q1 25 | $0.10 | $0.16 | ||
| Q4 24 | $-0.55 | $0.18 | ||
| Q3 24 | $-0.01 | $0.15 | ||
| Q2 24 | $0.06 | $0.21 | ||
| Q1 24 | $0.04 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $767.6M | $292.3M |
| 总债务越低越好 | $542.2M | — |
| 股东权益账面价值 | $2.1B | $512.5M |
| 总资产 | $2.9B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.26× | — |
8季度趋势，按日历期对齐
现金及短期投资RGENRVLV
| Q4 25 | $767.6M | $292.3M | ||
| Q3 25 | $748.7M | $315.4M | ||
| Q2 25 | $708.9M | $310.7M | ||
| Q1 25 | $697.2M | $300.8M | ||
| Q4 24 | $757.4M | $256.6M | ||
| Q3 24 | $784.0M | $252.8M | ||
| Q2 24 | $809.1M | $244.7M | ||
| Q1 24 | $780.6M | $273.4M |
总债务RGENRVLV
| Q4 25 | $542.2M | — | ||
| Q3 25 | $537.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $525.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RGENRVLV
| Q4 25 | $2.1B | $512.5M | ||
| Q3 25 | $2.1B | $490.2M | ||
| Q2 25 | $2.1B | $468.6M | ||
| Q1 25 | $2.0B | $453.4M | ||
| Q4 24 | $2.0B | $437.8M | ||
| Q3 24 | $2.0B | $420.8M | ||
| Q2 24 | $2.0B | $405.8M | ||
| Q1 24 | $2.0B | $389.9M |
总资产RGENRVLV
| Q4 25 | $2.9B | $765.0M | ||
| Q3 25 | $2.9B | $751.3M | ||
| Q2 25 | $2.9B | $722.9M | ||
| Q1 25 | $2.9B | $713.9M | ||
| Q4 24 | $2.8B | $665.5M | ||
| Q3 24 | $2.8B | $670.9M | ||
| Q2 24 | $2.9B | $657.8M | ||
| Q1 24 | $2.8B | $650.0M |
负债/权益比RGENRVLV
| Q4 25 | 0.26× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.7M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $17.6M | $-13.3M |
| 自由现金流率自由现金流/营收 | 8.9% | -4.1% |
| 资本支出强度资本支出/营收 | 4.1% | 1.0% |
| 现金转化率经营现金流/净利润 | 1.93× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $93.9M | $48.0M |
8季度趋势，按日历期对齐
经营现金流RGENRVLV
| Q4 25 | $25.7M | $-10.2M | ||
| Q3 25 | $48.1M | $11.8M | ||
| Q2 25 | $28.6M | $12.6M | ||
| Q1 25 | $15.0M | $45.1M | ||
| Q4 24 | $39.2M | $3.9M | ||
| Q3 24 | $49.3M | $9.1M | ||
| Q2 24 | $42.2M | $-24.7M | ||
| Q1 24 | $44.7M | $38.4M |
自由现金流RGENRVLV
| Q4 25 | $17.6M | $-13.3M | ||
| Q3 25 | $43.4M | $7.5M | ||
| Q2 25 | $21.5M | $10.4M | ||
| Q1 25 | $11.4M | $43.4M | ||
| Q4 24 | $33.6M | $2.1M | ||
| Q3 24 | $42.3M | $8.0M | ||
| Q2 24 | $37.4M | $-25.7M | ||
| Q1 24 | $36.4M | $36.7M |
自由现金流率RGENRVLV
| Q4 25 | 8.9% | -4.1% | ||
| Q3 25 | 23.0% | 2.5% | ||
| Q2 25 | 11.8% | 3.4% | ||
| Q1 25 | 6.8% | 14.6% | ||
| Q4 24 | 19.3% | 0.7% | ||
| Q3 24 | 27.3% | 2.8% | ||
| Q2 24 | 24.3% | -9.1% | ||
| Q1 24 | 24.0% | 13.5% |
资本支出强度RGENRVLV
| Q4 25 | 4.1% | 1.0% | ||
| Q3 25 | 2.5% | 1.5% | ||
| Q2 25 | 3.9% | 0.7% | ||
| Q1 25 | 2.1% | 0.6% | ||
| Q4 24 | 3.2% | 0.6% | ||
| Q3 24 | 4.5% | 0.4% | ||
| Q2 24 | 3.1% | 0.4% | ||
| Q1 24 | 5.5% | 0.6% |
现金转化率RGENRVLV
| Q4 25 | 1.93× | -0.55× | ||
| Q3 25 | 3.23× | 0.56× | ||
| Q2 25 | 1.92× | 1.24× | ||
| Q1 25 | 2.57× | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | 12.70× | -1.60× | ||
| Q1 24 | 21.35× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGEN
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
